Related Experiment Video
Updated: May 5, 2026

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Do Organism Profile and Resistance Patterns Change between First and Subsequent Two-Stage Revision for Periprosthetic
Helmut Ahrens1, Amelie Constanze Steinicke1, Georg Gosheger1
1Department of Orthopedics and Tumor Orthopedics, Muenster University Hospital, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany.
Abstract:
Increasing antibiotic resistance has been reported as an issue in the treatment of periprosthetic joint infection (PJI). A repeat two-stage revision for recurrent PJI is at high risk of reinfection. However, it is unclear if the microorganism profile plays a role with potentially more resistant or polymicrobial infections. This is a retrospective, single-center analysis of two-stage revisions performed between 2011 and 2017. We identified 46 patients who underwent a repeat resection arthroplasty for recurrent PJI of the same joint after a previous two-stage revision of the same joint at the same department. All microbiological findings were analyzed focusing on microbiological spectrum and resistance testing as well as the potential impact on reinfection-free survival. The most common organism found at the time of recurrent PJI were coagulase-negative Staphylococci (39%) followed by Gram-negative organisms (28%). The risk of polymicrobial infections, difficult-to-treat resistant organisms, and Gram-negative infections increased significantly. Among staphylococcal infections, there was a high percentage of methicillin-resistant species and resistance to oral antibiotics. Patients with Gram-negative organisms had a reduced infection-free survivorship, while resistant organisms were not associated with decreased survival. Patients who undergo a repeat two-stage revision for recurrent PJI have more polymicrobial and resistant organisms, although the impact on survivorship is unclear.
Insights
Repeat two-stage revision for periprosthetic joint infection (PJI) increases risk of polymicrobial and resistant infections. While Gram-negative organisms impact survival, resistant microbes did not significantly affect outcomes in this study.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Microbiology
Background:
- Periprosthetic joint infection (PJI) treatment is challenged by rising antibiotic resistance.
- Repeat two-stage revision surgery for recurrent PJI carries a high risk of reinfection.
- The role of microorganism profiles in recurrent PJI after repeat surgery remains unclear.
Purpose of the Study:
- To analyze the microorganism profile in patients undergoing repeat two-stage revision for recurrent PJI.
- To investigate the impact of microbial spectrum and resistance on reinfection-free survival.
Main Methods:
- Retrospective, single-center analysis of 46 patients undergoing repeat two-stage revision for PJI (2011-2017).
- Microbiological findings, including spectrum and resistance testing, were analyzed.
- Reinfection-free survival was assessed.
Main Results:
- Coagulase-negative Staphylococci (39%) and Gram-negative organisms (28%) were the most common pathogens.
- Significant increase in polymicrobial, difficult-to-treat resistant, and Gram-negative infections.
- Methicillin-resistant Staphylococci and oral antibiotic resistance were prevalent.
- Gram-negative infections were associated with reduced infection-free survivorship; resistant organisms were not.
Conclusions:
- Repeat two-stage revision for PJI is associated with a higher prevalence of polymicrobial and resistant organisms.
- The clinical impact of these resistant organisms on survivorship requires further investigation.
Related Concept Videos
Stages of Infection
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Endocarditis III: Medical Management
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

